Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe most effective exercise to combine with Wegovy is a mix of resistance training and steady aerobic activity — strength work to protect muscle as your weight falls, and cardio to support cardiovascular health and calorie balance. Starting gently and building gradually matters more than intensity, especially in the first few weeks when appetite changes and mild nausea are common. Wegovy (semaglutide) is a prescription-only medicine; whether it's right for you is a clinical decision, not a self-assessment. If you're already on treatment and wondering how to get more from it, this guide is for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The question most people ask is not really 'what exercise burns the most calories?', it's 'what will I still be doing in three months?' That answer is almost always something achievable. In the early weeks of Wegovy, your body is adjusting to semaglutide and appetite suppression is often strongest. Nausea, fatigue or dizziness can make high-intensity sessions impractical, and pushing through them rarely helps. Begin with 20–30 minutes of low-to-moderate activity three or four times a week. Brisk walking counts. So does cycling at a pace where you can hold a conversation, or a gentle swim. The aim here is consistency, not effort. Exercise isn't a mandatory condition of Wegovy treatment, but the evidence on Wegovy and exercise suggests people who move regularly alongside GLP-1 therapy retain more lean muscle, which matters for how you feel, not just the number on the scale.
One practical check you can do in under a minute: on your injection day, note in your phone how your energy feels six to twelve hours later. If fatigue is consistent, shift your more demanding sessions to days two and three of the week instead. Most people find their rhythm within a few weeks.
Once you're moving regularly, resistance training deserves its own dedicated slot. This is the part of exercise most commonly underestimated. When weight falls quickly (and Wegovy's trial results, reported in the STEP 1 study published in the New England Journal of Medicine, showed an average reduction of around 15% of body weight over 68 weeks) some of that reduction can include muscle mass if protein and strength work are insufficient. Resistance training signals to your body to hold onto the muscle it has. That means two sessions a week minimum, and they don't need to be in a gym. Bodyweight exercises (squats, lunges, press-ups, rows with a resistance band) are enough to begin with. Progress by adding repetitions or resistance, not by sprinting through sets. A structured weekly plan built around this principle is something our prescribers are happy to discuss as part of your ongoing care. If your joints are affected by your weight, water-based resistance work reduces load significantly and is worth exploring.
NHS England's guidance on weight-management medicines underlines that exercise and dietary support are expected alongside pharmacological treatment, not optional extras. That NHS England page covers the wraparound care approach in full and is worth reading if you're on or considering treatment.
With resistance sessions anchoring your week, aerobic work becomes the layer you build on top. The goal is to reach 150 minutes of moderate aerobic activity per week (the standard UK recommendation) but treat that as a horizon, not a week-one target. Progress by ten per cent or so each week: if you walked 30 minutes three times in week two, aim for 35 minutes or a fourth session in week three. Heart-rate guided training (keeping effort conversational or slightly breathless) is more sustainable than pace targets. Cycling, swimming, rowing, elliptical trainers and dancing all count. Semaglutide doesn't prevent exercise, most people find their capacity improves noticeably as weight comes down, often more quickly than they expected.
One thing to keep in mind: because Wegovy reduces appetite, it's easy to undereat relative to your output, particularly on days with longer sessions. This can cause fatigue or lightheadedness that gets mistakenly attributed to the medicine itself. Eating enough protein at each meal (25–30g is a reasonable guide, though personal needs vary) and staying well hydrated reduces that risk. If you're finding energy levels difficult to manage, that's worth raising at your next clinical review. Our semaglutide overview page covers how the medicine works alongside lifestyle changes.
Wegovy is titrated gradually, from 0.25mg through to 2.4mg or, for those who need it, up to 7.2mg with the recently approved higher-dose pen. Each dose increase can bring a temporary return of nausea or fatigue, similar to the first few weeks. Treat each step-up the same way you approached starting out: ease back slightly for a week, then rebuild. There's no benefit in pushing through significant nausea during a resistance session; rest is not failure. More detail on the Wegovy titration schedule is available on our Wegovy overview page.
If you are thinking about starting treatment and want to understand what the full picture looks like (medicine, clinical review, exercise, nutrition) our weight-loss treatments overview sets it out clearly. The cost of treatment, including what an all-in private prescription typically includes, is something many people want to understand before they begin, and our consultation page is the right starting point for that conversation with our prescribers.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.